Ube, Japan

Kousuke Morishita

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Ube Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kousuke Morishita. Retrieved from https://idiyas.com/inventor/kousuke-morishita

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kousuke Morishita: Innovator in Pharmaceutical Chemistry

Introduction

Kousuke Morishita is a notable inventor based in Ube, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on benzotriazole derivatives. His research focuses on compounds that exhibit Keap1 inhibitory effects, which have potential applications in various therapeutic areas.

Latest Patents

Morishita holds 1 patent for his invention related to benzotriazole derivatives. The patent describes a compound that provides a pharmaceutical composition containing the same. Specifically, the invention presents a compound represented by a general formula, along with its pharmaceutically acceptable salts.

Career Highlights

Kousuke Morishita is associated with Ube Corporation, a prominent company in the chemical and pharmaceutical industry. His work at Ube Corporation has allowed him to explore and develop innovative solutions that contribute to advancements in medicine.

Collaborations

Morishita has collaborated with notable colleagues, including Kazuhiro Onuma and Hiroyoshi Kawada. These collaborations have fostered a productive environment for research and development within the company.

Conclusion

Kousuke Morishita's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a key inventor in the industry. His work continues to influence the development of new therapeutic compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…